![](/img/cover-not-exists.png)
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial
Moscetti, Luca, Fabbri, Maria Agnese, Natoli, Clara, Vici, Patrizia, Gamucci, Teresa, Sperduti, Isabella, Iezzi, Laura, Iattoni, Elena, Pizzuti, Laura, Roma, Carmine, Vaccaro, Angela, D’Auria, GiulianVolume:
8
Journal:
Oncotarget
DOI:
10.18632/oncotarget.17262
Date:
August, 2017
File:
PDF, 1.70 MB
2017